Rolaids Tablet, Chewable
FDA Label NDC 84126-348

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by The Procter & Gamble Manufacturing Company for the product Rolaids (NDC 84126-348). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient (in each chewable tablet), purpose, uses, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

Antacid

If Pregnant Or Breast Feeding,

ask a health professional before use.

Keep Out Of Reach Of Children.

Directions

  • fully chew before swallowing
  • adults and children 12 years and over: 1 chewable tablet as symptoms occur, or as directed by a doctor
  • do not take for symptoms that persist for more than 2 weeks unless advised by a doctor

Other Information

  • each chewable tablet contains: calcium 400 mg
  • store at no greater than 25°C. Avoid excessive heat (over 40°C).

Questions?

Call
1-833-372-2729

* Please review the disclaimer below.